In a recent installment of the International Society of Automation’s “Ask the Automation Pros” series, Erik Cornelsen, ...
Inflection Point Acquisition Corp. IV does not have any significant business. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or ...
Palantir Technologies Inc. faces steep downside risk as extreme valuation meets weakening signals and insider selling. Click ...
AstraZeneca has had a setback in its late-stage oncology pipeline, after AKT inhibitor ceralasertib, given in combination with cancer immunotherapy Imfinzi, failed to extend survival in a lung cancer ...
The FDA has delivered a Commissioner's National Priority Voucher (CNPV) to Johnson & Johnson for a combination regimen based on Tecvayli for multiple myeloma. The latest voucher in the controversial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback